Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
Practical Guide: Oligo (dT) 25 Beads for Eukaryotic mRNA Iso
2026-05-11
Oligo (dT) 25 Beads provide a reliable method for isolating polyadenylated mRNA from eukaryotic samples, streamlining preparation for sensitive applications like cDNA synthesis and RT-PCR. They are not suitable for non-polyA mRNA or prokaryotic RNA purification. Use within recommended storage and handling guidelines to ensure consistent performance.
-
Streptavidin-FITC in High-Sensitivity Biotin Detection: Mech
2026-05-11
Explore the advanced mechanism and practical optimization of Streptavidin-FITC for high-sensitivity biotin detection. This article goes beyond typical overviews by integrating new mechanistic findings and protocol guidance for superior performance in immunofluorescence and nanoparticle tracking.
-
Antidepressant Effects of Rotigotine in Preclinical Depressi
2026-05-10
This study systematically evaluated rotigotine, a dopamine D2/D3 receptor agonist, for its antidepressant potential in established rodent models of depression and anxiety. The findings demonstrate that rotigotine, at select dosing regimens, can reverse depressive-like behaviors, supporting its utility as a dopaminergic signaling pathway modulator in neuropsychiatric research.
-
Antidepressant Actions of Rotigotine in Preclinical Depressi
2026-05-09
This study rigorously evaluates rotigotine, a dopamine D2/D3 receptor agonist, for its antidepressant potential in validated rodent models of depression. The findings reveal dose-dependent behavioral improvements, supporting rotigotine’s dual relevance for Parkinson’s disease and mood disorder research.
-
Taltirelin Acetate: Neuroprotection Workflows and Research I
2026-05-08
Taltirelin acetate unlocks sustained dopamine modulation and neuroprotection in Parkinson’s disease models, outperforming conventional agents by minimizing dyskinesia risk. Discover protocol parameters, troubleshooting strategies, and advanced applied use-cases for APExBIO’s trusted reagent.
-
Indomethacin in Inflammation and Lipid Metabolism Research
2026-05-08
Indomethacin stands out for its dual action as a Cox-1 selective inhibitor and PPARγ agonist, making it indispensable for advanced inflammation and lipid metabolism studies. This guide translates recent mechanistic insights into practical workflows, with protocol tips and troubleshooting for maximizing reproducibility.
-
Fulvestrant (ICI 182,780): Advanced Workflows in ER-Positive
2026-05-07
Fulvestrant (ICI 182,780) is a gold-standard estrogen receptor antagonist that enables precise experimental dissection of ER signaling, MDM2 protein degradation, and apoptosis induction in breast cancer cells. This article demystifies protocol optimization, troubleshooting, and translational applications, empowering researchers to maximize experimental power with APExBIO’s trusted reagent.
-
DGLA-Induced Ferroptosis via ACSL4 in AML: Lipid Metabolism
2026-05-07
This study demonstrates that exogenous dihomo-γ-linolenic acid (DGLA) triggers ferroptosis in acute myeloid leukemia (AML) cells through ACSL4-mediated lipid metabolic reprogramming. The findings uncover metabolic vulnerabilities in AML and propose ferroptosis induction as a potential therapeutic strategy against chemoresistant leukemia.
-
Transdermal Delivery of PTEN mRNA via HA-LNPs for Melanoma I
2026-05-06
This article reviews a recent study demonstrating the use of hyaluronated lipid nanoparticles (HA-LNPs) to deliver PTEN mRNA transdermally for localized melanoma immunotherapy. The research highlights the advantages of HA-LNPs for targeted, non-invasive mRNA delivery, restoration of tumor suppressor function, and enhancement of antitumor immune responses, providing an innovative platform for cancer gene therapy.
-
PreScission Protease: Precision Tag Cleavage for Protein Pur
2026-05-06
PreScission Protease (PSP) enables ultra-specific, low-temperature cleavage of fusion protein tags, maximizing recovery of native proteins even from fragile constructs. Its HRV 3C protease design outperforms conventional enzymes, particularly in workflows targeting nuclear condensates and chromatin-associated proteins.
-
LY2886721: Shaping BACE1 Inhibition Strategies in Alzheimer’
2026-05-05
Explore how LY2886721, a nanomolar-potent oral BACE1 inhibitor, enables a new generation of translational Alzheimer’s disease research. This thought-leadership article integrates mechanistic insight, preclinical validation, and strategic guidance to inform the design and interpretation of amyloid beta reduction studies, referencing the latest findings on synaptic safety and workflow optimization.
-
dKeap1 Forms Nuclear Condensates in Oxidative Stress Respons
2026-05-05
This study reveals that Drosophila Keap1 (dKeap1) assembles into nuclear condensates via phase separation in response to oxidative stress, requiring specific domain architecture and intrinsically disordered regions. These findings deepen our understanding of Keap1's nuclear functions and provide a new mechanistic link between oxidative signaling, chromatin organization, and gene regulation.
-
Plerixafor (AMD3100): Advancing CXCR4 Axis Modulation in Tra
2026-05-04
This thought-leadership article critically examines the mechanistic underpinnings and strategic applications of Plerixafor (AMD3100) as a CXCR4 chemokine receptor antagonist. By integrating new comparative evidence from colorectal cancer models and synthesizing cross-domain workflows in cancer metastasis and stem cell mobilization, we provide translational researchers with actionable insights for leveraging this gold-standard molecule, while contextualizing its evolving competitive landscape. Distinct from standard product guides, this piece bridges mechanistic depth with forward-looking guidance, supporting experimental design and clinical translation.
-
LY2886721: BACE Inhibitor Workflows for Alzheimer’s Disease
2026-05-04
LY2886721, a furothiazine-based oral BACE inhibitor, empowers Alzheimer's disease researchers to achieve precise, evidence-backed amyloid beta modulation in vitro and in vivo. This article delivers advanced workflow insights, troubleshooting solutions, and practical protocol parameters to optimize BACE1 enzyme inhibition studies, all grounded in recent translational findings.
-
Triiodothyronine in Adipocyte Thermogenesis: Mechanisms & St
2026-05-03
Explore the integrated role of Triiodothyronine (T3) in adipocyte biology, with an emphasis on advanced mechanisms in beige adipocyte thermogenesis, strategic guidance for translational researchers, and the utility of APExBIO's high-purity T3 in metabolic research workflows. This article bridges mechanistic insights with practical protocol parameters and competitive analysis, drawing on recent findings about SEMA3E and β-catenin signaling.